Log In
Print this Print this

radiprodil (RGH-896)

  Manage Alerts
Collapse Summary General Information
Company Gedeon Richter Ltd.
DescriptionOral NMDA receptor subunit 2B (NR2B) antagonist
Molecular Target NMDA receptor
Mechanism of ActionNMDA receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat neuropathic pain associated with diabetic peripheral neuropathy (DPNP); Treat pain
Regulatory Designation
PartnerAllergan plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today